List of Tables
Table 1. Global Hypereosinophilic Syndrome Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Hypereosinophilic Syndrome Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Hypereosinophilic Syndrome Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hypereosinophilic Syndrome Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Hypereosinophilic Syndrome Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Hypereosinophilic Syndrome Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Hypereosinophilic Syndrome Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Hypereosinophilic Syndrome Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Hypereosinophilic Syndrome Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hypereosinophilic Syndrome Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hypereosinophilic Syndrome Drug, Product Type & Application
Table 12. Global Key Manufacturers of Hypereosinophilic Syndrome Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hypereosinophilic Syndrome Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypereosinophilic Syndrome Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hypereosinophilic Syndrome Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Hypereosinophilic Syndrome Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Hypereosinophilic Syndrome Drug Sales Market Share by Region (2020-2025)
Table 19. Global Hypereosinophilic Syndrome Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Hypereosinophilic Syndrome Drug Sales Market Share by Region (2026-2031)
Table 21. Global Hypereosinophilic Syndrome Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Hypereosinophilic Syndrome Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Hypereosinophilic Syndrome Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Hypereosinophilic Syndrome Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Hypereosinophilic Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Hypereosinophilic Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Hypereosinophilic Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Hypereosinophilic Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Hypereosinophilic Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Hypereosinophilic Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Hypereosinophilic Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Hypereosinophilic Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Hypereosinophilic Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Hypereosinophilic Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Hypereosinophilic Syndrome Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Hypereosinophilic Syndrome Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Hypereosinophilic Syndrome Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Hypereosinophilic Syndrome Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Hypereosinophilic Syndrome Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hypereosinophilic Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Hypereosinophilic Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Hypereosinophilic Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Hypereosinophilic Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Hypereosinophilic Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Hypereosinophilic Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Hypereosinophilic Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Hypereosinophilic Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Hypereosinophilic Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Hypereosinophilic Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Hypereosinophilic Syndrome Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Hypereosinophilic Syndrome Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Hypereosinophilic Syndrome Drug Sales Market Share by Type (2020-2025)
Table 53. Global Hypereosinophilic Syndrome Drug Sales Market Share by Type (2026-2031)
Table 54. Global Hypereosinophilic Syndrome Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Hypereosinophilic Syndrome Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Hypereosinophilic Syndrome Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Hypereosinophilic Syndrome Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Hypereosinophilic Syndrome Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Hypereosinophilic Syndrome Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Hypereosinophilic Syndrome Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Hypereosinophilic Syndrome Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Hypereosinophilic Syndrome Drug Sales Market Share by Application (2020-2025)
Table 63. Global Hypereosinophilic Syndrome Drug Sales Market Share by Application (2026-2031)
Table 64. Global Hypereosinophilic Syndrome Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Hypereosinophilic Syndrome Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Hypereosinophilic Syndrome Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Hypereosinophilic Syndrome Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Hypereosinophilic Syndrome Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Hypereosinophilic Syndrome Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. Bristol-Myers Squibb Co Company Information
Table 71. Bristol-Myers Squibb Co Description and Business Overview
Table 72. Bristol-Myers Squibb Co Hypereosinophilic Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Bristol-Myers Squibb Co Hypereosinophilic Syndrome Drug Product
Table 74. Bristol-Myers Squibb Co Recent Developments/Updates
Table 75. GlaxoSmithKline Plc Company Information
Table 76. GlaxoSmithKline Plc Description and Business Overview
Table 77. GlaxoSmithKline Plc Hypereosinophilic Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. GlaxoSmithKline Plc Hypereosinophilic Syndrome Drug Product
Table 79. GlaxoSmithKline Plc Recent Developments/Updates
Table 80. Knopp Biosciences LLC Company Information
Table 81. Knopp Biosciences LLC Description and Business Overview
Table 82. Knopp Biosciences LLC Hypereosinophilic Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Knopp Biosciences LLC Hypereosinophilic Syndrome Drug Product
Table 84. Knopp Biosciences LLC Recent Developments/Updates
Table 85. Kyowa Hakko Kirin Co Ltd Company Information
Table 86. Kyowa Hakko Kirin Co Ltd Description and Business Overview
Table 87. Kyowa Hakko Kirin Co Ltd Hypereosinophilic Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Kyowa Hakko Kirin Co Ltd Hypereosinophilic Syndrome Drug Product
Table 89. Kyowa Hakko Kirin Co Ltd Recent Developments/Updates
Table 90. Stemline Therapeutics Inc Company Information
Table 91. Stemline Therapeutics Inc Description and Business Overview
Table 92. Stemline Therapeutics Inc Hypereosinophilic Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Stemline Therapeutics Inc Hypereosinophilic Syndrome Drug Product
Table 94. Stemline Therapeutics Inc Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Hypereosinophilic Syndrome Drug Distributors List
Table 98. Hypereosinophilic Syndrome Drug Customers List
Table 99. Hypereosinophilic Syndrome Drug Market Trends
Table 100. Hypereosinophilic Syndrome Drug Market Drivers
Table 101. Hypereosinophilic Syndrome Drug Market Challenges
Table 102. Hypereosinophilic Syndrome Drug Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hypereosinophilic Syndrome Drug
Figure 2. Global Hypereosinophilic Syndrome Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hypereosinophilic Syndrome Drug Market Share by Type: 2024 & 2031
Figure 4. Benralizumab Product Picture
Figure 5. Dasatinib Product Picture
Figure 6. Dexpramipexole Dihydrochloride Product Picture
Figure 7. Mepolizumab Product Picture
Figure 8. Others Product Picture
Figure 9. Global Hypereosinophilic Syndrome Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Hypereosinophilic Syndrome Drug Market Share by Application: 2024 & 2031
Figure 11. Research Center
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Global Hypereosinophilic Syndrome Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Hypereosinophilic Syndrome Drug Market Size (2020-2031) & (US$ Million)
Figure 16. Global Hypereosinophilic Syndrome Drug Sales (2020-2031) & (K Pcs)
Figure 17. Global Hypereosinophilic Syndrome Drug Average Price (USD/Pcs) & (2020-2031)
Figure 18. Hypereosinophilic Syndrome Drug Report Years Considered
Figure 19. Hypereosinophilic Syndrome Drug Sales Share by Manufacturers in 2024
Figure 20. Global Hypereosinophilic Syndrome Drug Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Hypereosinophilic Syndrome Drug Players: Market Share by Revenue in Hypereosinophilic Syndrome Drug in 2024
Figure 22. Hypereosinophilic Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Hypereosinophilic Syndrome Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Hypereosinophilic Syndrome Drug Sales Market Share by Country (2020-2031)
Figure 25. North America Hypereosinophilic Syndrome Drug Revenue Market Share by Country (2020-2031)
Figure 26. U.S. Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Hypereosinophilic Syndrome Drug Sales Market Share by Country (2020-2031)
Figure 29. Europe Hypereosinophilic Syndrome Drug Revenue Market Share by Country (2020-2031)
Figure 30. Germany Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Hypereosinophilic Syndrome Drug Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Hypereosinophilic Syndrome Drug Revenue Market Share by Region (2020-2031)
Figure 37. China Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Taiwan Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Philippines Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Hypereosinophilic Syndrome Drug Sales Market Share by Country (2020-2031)
Figure 48. Latin America Hypereosinophilic Syndrome Drug Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Hypereosinophilic Syndrome Drug Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Hypereosinophilic Syndrome Drug Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Hypereosinophilic Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Hypereosinophilic Syndrome Drug by Type (2020-2031)
Figure 58. Global Revenue Market Share of Hypereosinophilic Syndrome Drug by Type (2020-2031)
Figure 59. Global Hypereosinophilic Syndrome Drug Price (USD/Pcs) by Type (2020-2031)
Figure 60. Global Sales Market Share of Hypereosinophilic Syndrome Drug by Application (2020-2031)
Figure 61. Global Revenue Market Share of Hypereosinophilic Syndrome Drug by Application (2020-2031)
Figure 62. Global Hypereosinophilic Syndrome Drug Price (USD/Pcs) by Application (2020-2031)
Figure 63. Hypereosinophilic Syndrome Drug Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
